Eric Bjerkholt, CFO, on July 06, 2026, sold 5,000 shares in Mirum Pharmaceuticals (MIRM) for $611,273. Following the Form 4 filing with the SEC, Bjerkholt has control over a total of 42,181 common shares of the company, with 42,181 shares held directly.
SEC Filing: